{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:50:16Z","timestamp":1787237416810,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s00702-023-02709-3","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T05:01:38Z","timestamp":1697605298000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The specific NQO2 inhibitor, S29434, only marginally improves the survival of dopamine neurons in MPTP-intoxicated mice"],"prefix":"10.1007","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9645-0553","authenticated-orcid":false,"given":"Maeva","family":"Vallucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0068-7204","authenticated-orcid":false,"given":"Jean A.","family":"Boutin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6787-7291","authenticated-orcid":false,"given":"Elzbieta","family":"Janda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Blandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8695-8548","authenticated-orcid":false,"given":"Ruth","family":"Musgrove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8296-836X","authenticated-orcid":false,"given":"Donato","family":"Di Monte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0689-7923","authenticated-orcid":false,"given":"Gilles","family":"Ferry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5607-3119","authenticated-orcid":false,"given":"Patrick P.","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4823-276X","authenticated-orcid":false,"given":"Etienne C.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,18]]},"reference":[{"issue":"3","key":"2709_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF03033137","volume":"5","author":"M Asanuma","year":"2003","unstructured":"Asanuma M, Miyazaki I, Ogawa N (2003) Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson\u2019s disease. Neurotox Res 5(3):165\u2013176","journal-title":"Neurotox Res"},{"issue":"38","key":"2709_CR2","doi-asserted-by":"publisher","first-page":"12690","DOI":"10.1523\/JNEUROSCI.2808-10.2010","volume":"30","author":"C-E Benoit","year":"2010","unstructured":"Benoit C-E, Bastianetto S, Brouillette J, Tse Y, Boutin JA, Delagrange P, Wong T, Sarret P, Quirion R (2010) Loss of quinone reductase 2 function selectively facilitates learning behaviors. J Neurosci 30(38):12690\u201312700","journal-title":"J Neurosci"},{"issue":"3","key":"2709_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1124\/mol.118.114231","volume":"95","author":"JA Boutin","year":"2019","unstructured":"Boutin JA, Bouillaud F, Janda E, Gacsalyi I, Guillaumet G, Hirsch EC, Kane DA, Nepveu F, Reybier K, Dupuis P, Bertrand M, Chhour M, Le Diguarher T, Antoine M, Brebner K, Da Costa H, Ducrot P, Giganti A, Goswami V, Guedouari H, Michel PP, Patel A, Paysant J, Stojko J, Viaud-Massuard M-C, Ferry G (2019) S29434, a quinone reductase 2 inhibitor: main biochemical and cellular characterization. Mol Pharmacol 95(3):269\u2013285","journal-title":"Mol Pharmacol"},{"issue":"11","key":"2709_CR4","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/j.neurobiolaging.2007.04.007","volume":"29","author":"J Brouillette","year":"2008","unstructured":"Brouillette J, Quirion R (2008) Transthyretin: a key gene involved in the maintenance of memory capacities during aging. Neurobiol Aging 29(11):1721\u20131732","journal-title":"Neurobiol Aging"},{"key":"2709_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.freeradbiomed.2015.07.150","volume":"89","author":"L-E Cassagnes","year":"2015","unstructured":"Cassagnes L-E, Perio P, Ferry G, Moulharat N, Antoine M, Gayon R, Boutin JA, Nepveu F, Reybier K (2015) In cellulo monitoring of quinone reductase activity and reactive oxygen species production during the redox cycling of 1,2 and 1,4 quinones. Free Radic Biol Med 89:126\u2013134","journal-title":"Free Radic Biol Med"},{"key":"2709_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.freeradbiomed.2018.03.002","volume":"120","author":"L-E Cassagnes","year":"2018","unstructured":"Cassagnes L-E, Chhour M, P\u00e9rio P, Sudor J, Gayon R, Ferry G, Boutin JA, Nepveu F, Reybier K (2018) Oxidative stress and neurodegeneration: the possible contribution of quinone reductase 2. Free Radic Biol Med 120:56\u201361","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"2709_CR7","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3390\/antiox9070597","volume":"9","author":"K-H Chang","year":"2020","unstructured":"Chang K-H, Chen C-M (2020) The role of oxidative stress in Parkinson\u2019s disease. Antioxidants (basel) 9(7):597","journal-title":"Antioxidants (basel)"},{"issue":"6","key":"2709_CR8","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1177\/096032719201100616","volume":"11","author":"MT Corasaniti","year":"1992","unstructured":"Corasaniti MT, Bagetta G, Rodin\u00f2 P, Gratteri S, Nistic\u00f2 G (1992) Neurotoxic effects induced by intracerebral and systemic injection of paraquat in rats. Hum Exp Toxicol 11(6):535\u2013539","journal-title":"Hum Exp Toxicol"},{"issue":"1","key":"2709_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0773.1998.tb01434.x","volume":"83","author":"MT Corasaniti","year":"1998","unstructured":"Corasaniti MT, Strongoli MC, Rotiroti D, Bagetta G, Nistic\u00f2 G (1998) Paraquat: a useful tool for the in vivo study of mechanisms of neuronal cell death. Pharmacol Toxicol 83(1):1\u20137","journal-title":"Pharmacol Toxicol"},{"issue":"9","key":"2709_CR10","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1089\/ars.2009.2459","volume":"11","author":"AC Crist\u00f3v\u00e3o","year":"2009","unstructured":"Crist\u00f3v\u00e3o AC, Choi D-H, Baltazar G, Beal MF, Kim Y-S (2009) The role of NADPH oxidase 1-derived reactive oxygen species in paraquat-mediated dopaminergic cell death. Antioxid Redox Signal 11(9):2105\u20132118","journal-title":"Antioxid Redox Signal"},{"issue":"6","key":"2709_CR11","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/mds.25462","volume":"28","author":"B Dehay","year":"2013","unstructured":"Dehay B, Martinez-Vicente M, Caldwell GA, Caldwell KA, Yue Z, Cookson MR, Klein C, Vila M, Bezard E (2013) Lysosomal impairment in Parkinson\u2019s disease. Mov Disord 28(6):725\u2013732","journal-title":"Mov Disord"},{"issue":"11","key":"2709_CR12","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1016\/j.freeradbiomed.2008.02.008","volume":"44","author":"DA Drechsel","year":"2008","unstructured":"Drechsel DA, Patel M (2008) Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson\u2019s disease. Free Rad Biol Med 44(11):1873\u20131886","journal-title":"Free Rad Biol Med"},{"issue":"35","key":"2709_CR13","doi-asserted-by":"publisher","first-page":"23829","DOI":"10.1074\/jbc.M801371200","volume":"283","author":"Y Fu","year":"2008","unstructured":"Fu Y, Buryanovskyy L, Zhang Z (2008) Quinone reductase 2 is a catechol quinone reductase. J Biol Chem 283(35):23829\u201323835","journal-title":"J Biol Chem"},{"issue":"3","key":"2709_CR14","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1093\/brain\/awac445","volume":"146","author":"M Gonzalez-Sepulveda","year":"2023","unstructured":"Gonzalez-Sepulveda M, Compte J, Cuadros T, Nicolau A, Guillard-Sirieix C, Pe\u00f1uelas N, Lorente-Picon M, Parent A, Romero-Gim\u00e9nez J, Cladera-Sastre JM, Laguna A, Vila M (2023) In vivo reduction of age-dependent neuromelanin accumulation mitigates features of Parkinson\u2019s disease. Brain 146(3):1040\u20131052","journal-title":"Brain"},{"issue":"45","key":"2709_CR15","doi-asserted-by":"publisher","first-page":"8698","DOI":"10.1523\/JNEUROSCI.1243-20.2020","volume":"40","author":"NL Gould","year":"2020","unstructured":"Gould NL, Sharma V, Hleihil M, Kolatt Chandran S, David O, Edry E, Rosenblum K (2020) Dopamine-dependent QR2 pathway activation in CA1 interneurons enhances novel memory formation. J Neurosci 40(45):8698\u20138714","journal-title":"J Neurosci"},{"key":"2709_CR16","doi-asserted-by":"publisher","first-page":"e162120","DOI":"10.1172\/JCI162120","volume":"133","author":"NL Gould","year":"2023","unstructured":"Gould NL, Scherer GR, Carvalho S, Shurrush K, Kayyal H, Edry E, Elkobi A, David O, Foqara M, Thakar D, Pavesi T, Sharma V, Walker M, Maitland M, Dym O, Albeck S, Peleg Y, Germain N, Babaev I, Sharir H, Lalzar M, Shklyar B, Hazut N, Khamaisy M, L\u00e9vesque M, Lajoie G, Avoli M, Amitai G, Lefker B, Subramanyam C, Shilton B, Barr H, Rosenblum K (2023) Specific quinone reductase 2 inhibitors reduce metabolic burden and reverse Alzheimer\u2019s disease phenotype in mice. J Clin Invest 133:e162120","journal-title":"J Clin Invest"},{"key":"2709_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101911","volume":"41","author":"X Han","year":"2021","unstructured":"Han X, Zhao S, Song H, Xu T, Fang Q, Hu G, Sun L (2021) Kaempferol alleviates LD-mitochondrial damage by promoting autophagy: Implications in Parkinson\u2019s disease. Redox Biol 41:101911","journal-title":"Redox Biol"},{"issue":"4","key":"2709_CR18","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1006\/bbrc.2001.5868","volume":"288","author":"S Harada","year":"2001","unstructured":"Harada S, Fujii C, Hayashi A, Ohkoshi N (2001) An association between idiopathic Parkinson\u2019s disease and polymorphisms of phase II detoxification enzymes: glutathione S-transferase M1 and quinone oxidoreductase 1 and 2. Biochem Biophys Res Commun 288(4):887\u2013892","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2709_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neulet.2011.07.008","volume":"502","author":"T Hashimoto","year":"2011","unstructured":"Hashimoto T, Nakai M (2011) Increased hippocampal quinone reductase 2 in Alzheimer\u2019s disease. Neurosci Lett 502(1):10\u201312","journal-title":"Neurosci Lett"},{"issue":"Suppl","key":"2709_CR20","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1002\/ana.410320715","volume":"32","author":"EC Hirsch","year":"1992","unstructured":"Hirsch EC (1992) Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson\u2019s disease? Ann Neurol 32(Suppl):S88\u2013S93","journal-title":"Ann Neurol"},{"issue":"6180","key":"2709_CR21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/334345a0","volume":"334","author":"E Hirsch","year":"1988","unstructured":"Hirsch E, Graybiel AM, Agid YA (1988) Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson\u2019s disease. Nature 334(6180):345\u2013348","journal-title":"Nature"},{"key":"2709_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/978-3-7091-0643-3_6","volume":"65","author":"EC Hirsch","year":"2003","unstructured":"Hirsch EC, H\u00f6glinger G, Rousselet E, Breidert T, Parain K, Feger J, Ruberg M, Prigent A, Cohen-Salmon C, Launay JM (2003) Animal models of Parkinson\u2019s disease in rodents induced by toxins: an update. J Neural Transm Suppl 65:89\u2013100","journal-title":"J Neural Transm Suppl"},{"issue":"18","key":"2709_CR23","doi-asserted-by":"publisher","first-page":"10808","DOI":"10.3390\/ijms231810808","volume":"23","author":"M Huang","year":"2022","unstructured":"Huang M, Bargues-Carot A, Riaz Z, Wickham H, Zenitsky G, Jin H, Anantharam V, Kanthasamy A, Kanthasamy AG (2022) Impact of environmental risk factors on mitochondrial dysfunction, neuroinflammation, protein misfolding, and oxidative stress in the etiopathogenesis of Parkinson\u2019s Disease. Int J Mol Sci 23(18):10808","journal-title":"Int J Mol Sci"},{"issue":"20","key":"2709_CR24","doi-asserted-by":"publisher","first-page":"14502","DOI":"10.1016\/S0021-9258(17)36651-6","volume":"269","author":"AK Jaiswal","year":"1994","unstructured":"Jaiswal AK (1994) Human NAD(P)H:quinone oxidoreductase2. Gene structure, activity, and tissue-specific expression. J Biol Chem 269(20):14502\u201314508","journal-title":"J Biol Chem"},{"issue":"3","key":"2709_CR25","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s12035-012-8318-1","volume":"46","author":"E Janda","year":"2012","unstructured":"Janda E, Isidoro C, Carresi C, Mollace V (2012) Defective autophagy in Parkinson\u2019s disease: role of oxidative stress. Mol Neurobiol 46(3):639\u2013661","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2709_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1476-5381.2012.01870.x","volume":"168","author":"E Janda","year":"2013","unstructured":"Janda E, Parafati M, Aprigliano S, Carresi C, Visalli V, Sacco I, Ventrice D, Mega T, Vadal\u00e1 N, Rinaldi S, Musolino V, Palma E, Gratteri S, Rotiroti D, Mollace V (2013) The antidote effect of quinone oxidoreductase 2 inhibitor against paraquat-induced toxicity in vitro and in vivo. Br J Pharmacol 168(1):46\u201359","journal-title":"Br J Pharmacol"},{"issue":"7","key":"2709_CR27","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1080\/15548627.2015.1058683","volume":"11","author":"E Janda","year":"2015","unstructured":"Janda E, Lascala A, Carresi C, Parafati M, Aprigliano S, Russo V, Savoia C, Ziviani E, Musolino V, Morani F, Isidoro C, Mollace V (2015) Parkinsonian toxin-induced oxidative stress inhibits basal autophagy in astrocytes via NQO2\/quinone oxidoreductase 2: Implications for neuroprotection. Autophagy 11(7):1063\u20131080","journal-title":"Autophagy"},{"issue":"5","key":"2709_CR28","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1124\/molpharm.120.000105","volume":"98","author":"E Janda","year":"2020","unstructured":"Janda E, Nepveu F, Calamini B, Ferry G, Boutin JA (2020) Molecular pharmacology of NRH: quinone oxidoreductase 2: a detoxifying enzyme acting as an undercover toxifying enzyme. Mol Pharmacol 98(5):620\u2013633","journal-title":"Mol Pharmacol"},{"issue":"5","key":"2709_CR29","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3390\/antiox10050776","volume":"10","author":"E Janda","year":"2021","unstructured":"Janda E, Martino C, Riillo C, Parafati M, Lascala A, Mollace V, Boutin JA (2021) Apigenin and luteolin regulate autophagy by targeting NRH-quinone oxidoreductase 2 in liver cells. Antioxidants (basel) 10(5):776","journal-title":"Antioxidants (basel)"},{"key":"2709_CR30","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-2510273\/v1","author":"E Janda","year":"2023","unstructured":"Janda E, Parafati M, Martino C, William JNG, Reybier K, Mollace V, Boutin JA (2023) Autophagy and neuroprotection in astrocytes exposed to 6-hydroxydopamine is negatively regulated by NQO2: a potential novel target in Parkinson\u2019s disease. Sci Reports. https:\/\/doi.org\/10.21203\/rs.3.rs-2510273\/v1","journal-title":"Sci Reports"},{"issue":"8","key":"2709_CR31","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/0024-3205(86)90589-8","volume":"38","author":"JN Johannessen","year":"1986","unstructured":"Johannessen JN, Adams JD, Schuller HM, Bacon JP, Markey SP (1986) 1-methyl-4-phenylpyridine (MPP+) induces oxidative stress in the rodent. Life Sci 38(8):743\u2013749","journal-title":"Life Sci"},{"issue":"2","key":"2709_CR32","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s10787-023-01141-z","volume":"31","author":"S Kartik","year":"2023","unstructured":"Kartik S, Pal R, Chaudhary MJ, Nath R, Kumar M, Binwal M, Bawankule DU (2023) Neuroprotective role of chloroquine via modulation of autophagy and neuroinflammation in MPTP-induced Parkinson\u2019s disease. Inflammopharmacology 31(2):927\u2013941","journal-title":"Inflammopharmacology"},{"issue":"3","key":"2709_CR33","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/j.1471-4159.1993.tb03616.x","volume":"61","author":"A Kastner","year":"1993","unstructured":"Kastner A, Hirsch EC, Herrero MT, Javoy-Agid F, Agid Y (1993) Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson\u2019s and Alzheimer\u2019s disease. J Neurochem 61(3):1024\u20131034","journal-title":"J Neurochem"},{"issue":"10","key":"2709_CR34","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s00702-014-1185-3","volume":"121","author":"A Kupsch","year":"2014","unstructured":"Kupsch A, Schmidt W, Gizatullina Z, Debska-Vielhaber G, Voges J, Striggow F, Panther P, Schwegler H, Heinze H-J, Vielhaber S, Gellerich FN (2014) 6-Hydroxydopamine impairs mitochondrial function in the rat model of Parkinson\u2019s disease: respirometric, histological, and behavioral analyses. J Neural Transm (vienna) 121(10):1245\u20131257","journal-title":"J Neural Transm (vienna)"},{"issue":"s1","key":"2709_CR35","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.3233\/JPD-179006","volume":"7","author":"JW Langston","year":"2017","unstructured":"Langston JW (2017) The MPTP story. J Parkinson\u2019s Dis 7(s1):S11\u2013S19","journal-title":"J Parkinson\u2019s Dis"},{"issue":"4669","key":"2709_CR36","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1126\/science.6332378","volume":"225","author":"JW Langston","year":"1984","unstructured":"Langston JW, Irwin I, Langston EB, Forno LS (1984) Pargyline prevents MPTP-induced parkinsonism in primates. Science 225(4669):1480\u20131482","journal-title":"Science"},{"issue":"6","key":"2709_CR37","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1083\/jcb.201607005","volume":"214","author":"C-Y Lim","year":"2016","unstructured":"Lim C-Y, Zoncu R (2016) The lysosome as a command-and-control center for cellular metabolism. J Cell Biol 214(6):653\u2013664","journal-title":"J Cell Biol"},{"issue":"5","key":"2709_CR38","first-page":"1395","volume":"48","author":"Z Liu","year":"2023","unstructured":"Liu Z, Zhuang W, Cai M, Lv E, Wang Y, Wu Z, Wang H, Fu W (2023) Kaemperfol protects dopaminergic neurons by promoting mTOR-mediated autophagy in Parkinson\u2019s disease models. Neurochem Res 48(5):1395\u20131411","journal-title":"Neurochem Res"},{"issue":"4","key":"2709_CR39","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s10534-017-0030-1","volume":"30","author":"H Lu","year":"2017","unstructured":"Lu H, Chen J, Huang H, Zhou M, Zhu Q, Yao SQ, Chai Z, Hu Y (2017) Iron modulates the activity of monoamine oxidase B in SH-SY5Y cells. Biometals 30(4):599\u2013607","journal-title":"Biometals"},{"issue":"1\u20132","key":"2709_CR40","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.febslet.2004.10.083","volume":"578","author":"F Mailliet","year":"2004","unstructured":"Mailliet F, Ferry G, Vella F, Thiam K, Delagrange P, Boutin JA (2004) Organs from mice deleted for NRH:quinone oxidoreductase 2 are deprived of the melatonin binding site MT3. FEBS Lett 578(1\u20132):116\u2013120","journal-title":"FEBS Lett"},{"issue":"2","key":"2709_CR41","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.bmc.2009.11.059","volume":"18","author":"KA Nolan","year":"2010","unstructured":"Nolan KA, Humphries MP, Barnes J, Doncaster JR, Caraher MC, Tirelli N, Bryce RA, Whitehead RC, Stratford IJ (2010) Triazoloacridin-6-ones as novel inhibitors of the quinone oxidoreductases NQO1 and NQO2. Bioorg Med Chem 18(2):696\u2013706","journal-title":"Bioorg Med Chem"},{"issue":"11","key":"2709_CR42","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/S0006-2952(01)00615-3","volume":"61","author":"O Nosjean","year":"2001","unstructured":"Nosjean O, Nicolas J-P, Klupsch F, Delagrange P, Canet E, Boutin JA (2001) Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3\/QR2 tissue distribution of MT3\/QR2. Biochem Pharmacol 61(11):1369\u20131379","journal-title":"Biochem Pharmacol"},{"key":"2709_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2021.109380","volume":"336","author":"I Pantic","year":"2021","unstructured":"Pantic I, Cumic J, Skodric SR, Dugalic S, Brodski C (2021) Oxidopamine and oxidative stress: recent advances in experimental physiology and pharmacology. Chem Biol Interact 336:109380","journal-title":"Chem Biol Interact"},{"issue":"4","key":"2709_CR44","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1111\/cns.14090","volume":"29","author":"L-Y Ran","year":"2023","unstructured":"Ran L-Y, Xiang J, Zeng X-X, He W-W, Dong Y-T, Yu W-F, Qi X-L, Xiao Y, Cao K, Zou J, Guan Z-Z (2023) The influence of NQO2 on the dysfunctional autophagy and oxidative stress induced in the hippocampus of rats and in SH-SY5Y cells by fluoride. CNS Neurosci Ther 29(4):1129\u20131141","journal-title":"CNS Neurosci Ther"},{"issue":"47","key":"2709_CR45","doi-asserted-by":"publisher","first-page":"15568","DOI":"10.1523\/JNEUROSCI.1170-15.2015","volume":"35","author":"AN Rappaport","year":"2015","unstructured":"Rappaport AN, Jacob E, Sharma V, Inberg S, Elkobi A, Ounallah-Saad H, Pasmanik-Chor M, Edry E, Rosenblum K (2015) Expression of quinone reductase-2 in the cortex is a muscarinic acetylcholine receptor-dependent memory consolidation constraint. J Neurosci 35(47):15568\u201315581","journal-title":"J Neurosci"},{"issue":"10","key":"2709_CR46","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.3109\/10715762.2011.605788","volume":"45","author":"K Reybier","year":"2011","unstructured":"Reybier K, Perio P, Ferry G, Bouajila J, Delagrange P, Boutin JA, Nepveu F (2011) Insights into the redox cycle of human quinone reductase 2. Free Radic Res 45(10):1184\u20131195","journal-title":"Free Radic Res"},{"issue":"16","key":"2709_CR47","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.1111\/j.1742-4658.2009.07143.x","volume":"276","author":"S Sollner","year":"2009","unstructured":"Sollner S, Macheroux P (2009) New roles of flavoproteins in molecular cell biology: an unexpected role for quinone reductases as regulators of proteasomal degradation. FEBS J 276(16):4313\u20134324","journal-title":"FEBS J"},{"issue":"3","key":"2709_CR48","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/cbdv.200790032","volume":"4","author":"B Testa","year":"2007","unstructured":"Testa B, Kr\u00e4mer SD (2007) The biochemistry of drug metabolism\u2014an introduction: Part 2. Redox reactions and their enzymes. Chem Biodivers 4(3):257\u2013405","journal-title":"Chem Biodivers"},{"issue":"1","key":"2709_CR49","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1134\/S1607672919050090","volume":"488","author":"YV Vakhitova","year":"2019","unstructured":"Vakhitova YV, Kuzmina US, Voronin MV, Zainullina LF, Seredenin SB (2019) Effect of fabomotizole on brain gene expression in MR rats in the open field test. Dokl Biochem Biophys 488(1):313\u2013315","journal-title":"Dokl Biochem Biophys"},{"issue":"1\u20132","key":"2709_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2005.09.019","volume":"71","author":"F Vella","year":"2005","unstructured":"Vella F, Ferry G, Delagrange P, Boutin JA (2005) NRH:quinone reductase 2: an enzyme of surprises and mysteries. Biochem Pharmacol 71(1\u20132):1\u201312","journal-title":"Biochem Pharmacol"},{"issue":"23","key":"2709_CR51","doi-asserted-by":"publisher","first-page":"13061","DOI":"10.3390\/ijms222313061","volume":"22","author":"MV Voronin","year":"2021","unstructured":"Voronin MV, Kadnikov IA, Zainullina LF, Logvinov IO, Verbovaya ER, Antipova TA, Vakhitova YV, Seredenin SB (2021) Neuroprotective properties of quinone reductase 2 inhibitor M-11, a 2-mercaptobenzimidazole derivative. Int J Mol Sci 22(23):13061","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2709_CR52","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1021\/np100373f","volume":"74","author":"J-H Yang","year":"2011","unstructured":"Yang J-H, Kondratyuk TP, Jermihov KC, Marler LE, Qiu X, Choi Y, Cao H, Yu R, Sturdy M, Huang R, Liu Y, Wang L-Q, Mesecar AD, van Breemen RB, Pezzuto JM, Fong HHS, Chen Y-G, Zhang H-J (2011) Bioactive compounds from the fern Lepisorus contortus. J Nat Prod 74(2):129\u2013136","journal-title":"J Nat Prod"},{"issue":"5","key":"2709_CR53","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1073\/pnas.94.5.1669","volume":"94","author":"Q Zhao","year":"1997","unstructured":"Zhao Q, Yang XL, Holtzclaw WD, Talalay P (1997) Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase). Proc Natl Acad Sci U S A 94(5):1669\u20131674","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-023-02709-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-023-02709-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-023-02709-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T11:22:04Z","timestamp":1704453724000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-023-02709-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,18]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["2709"],"URL":"https:\/\/doi.org\/10.1007\/s00702-023-02709-3","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,18]]},"assertion":[{"value":"30 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}